03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Rare diseases
Elena Maksimkina
head of the Federal Center for Drug Planning and Provision (FCDPiLO)
press citation on 1 topic since 16 Jun 2026 · last quoted 16 Jun 2026
02 Quoted on · 1 of 29 topics
Elena Maksimkina: key facts
- Kind of voice
- Sector leader
- Role
- head of the Federal Center for Drug Planning and Provision (FCDPiLO)
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 16 Jun 2026
04 The signal · where Elena Maksimkina sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Karim MikhailSector leaderActing Director, Center for Biologics Evaluation and Research1
- 25=Mike DavisSector leaderActing Director, Center for Drug Evaluation and Research1
- 25=Elena MaksimkinaSector leaderhead of the Federal Center for Drug Planning and Provision (FCDPiLO)1
- 25=Alexander Hoischen, PhDAcademicprofessor of genomic technologies at Radboud University Medical Center1
- 25=Christian Gilissen, PhDAcademicprofessor of genome bioinformatics at Radboud University Medical Center1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Elena Maksimkina has said
- thepharmaletter.com1
Where Elena Maksimkina has been quoted
- 01Russia may revise patent protection terms for original drugsthepharmaletter.com · 16 Jun 2026
Verbatim
“implementation of these plans is important, as modern technologies allow to bring new molecules to the market much faster”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.